Shares of Healthways are recovering this morning — up almost 3 percent on normal volume — from the hit they took Tuesday after Citigroup analyst James Naklicki said investors should sell them. Naklicki expects Healthways to earn 50 cents per share next year, well below the consensus of 72 cents. He says spending on the company's new contracts and lower rates on renegotiated deals will keep down profit growth. Healthways (Ticker: HWAY) closed at $10.48 Tuesday, down 3 percent on the day. Naklicki's target for the stock is $9.
Analysts at BGB Securities have launched coverage of Pinnacle Financial Partners with a 'buy' rating and a $21.50 price target. That makes the firm a outlier: Every other analyst following the largest bank headquartered in Nashville rates its shares (Ticker: PNFP) at 'hold.' BGB's price target provides for about 17 percent of upside from Tuesday's close of $18.35.